My current view on the PPS for CTIX is that I would be happy if it for the next week or two just consolidates and holds above $2. Too strong an up move just invites minnie bear raids. We all have a view of where CTIX is going in the LONG RUN and already has moved up nicely in the last month. Patience is a good stratigy when you have a winner that is only just starting. In looking at some of the other BIOs that have had success in the recent past CTIX should be over $100 sometime in the next 4 years. Timing can be debated but not bad for a $1 or $2 stock depending on where you got in.
My current view on the PPS for CTIX is that I would be
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
NeuroPace, Inc. Faces Investigation Over Alleged Fraud Claims
Investigation of NeuroPace, Inc. NeuroPace, Inc., known for its innovations in medical technology, is currently under scrutiny as claims emerge regarding possible misconduct by its executives. These allegations primarily revolve around securities fraud and other business practices that have raised concerns among investors. Potential Securities Fraud The investigation...
Continue Reading
Dodge Charger Daytona: Power and Innovation Earn Awards
Dodge Charger Daytona's Groundbreaking Recognition The Dodge Charger Daytona stood out as a prime example of automotive innovation by earning the admiration of experts and enthusiasts alike. This remarkable vehicle has earned a prestigious accolade, listed among the 2025 Wards 10 Best Engines & Propulsion Systems. This recognition speaks volumes about its unprecedented...
Continue Reading
Understanding Riksbank Certificates: Key Details and Insights
Exploring the Riksbank Certificates: A Comprehensive Overview Riksbank certificates play a critical role in the financial market, serving as a vital instrument for liquidity management. Understanding the conditions surrounding these certificates can significantly benefit potential investors and financial institutions alike. Key Dates for Bidding and Settlement When...
Continue Reading
Akebia Therapeutics' New Stock Offering Aims for Growth
Akebia Unveils New Public Offering of Common Stock Akebia Therapeutics, Inc. (Nasdaq: AKBA), a dedicated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, has publicly announced the pricing details of its recent offering. This offering involves 25 million shares of common stock, each priced at $2.00, aiming to generate...
Continue Reading
Exciting Developments at Modera Lady Bird: A New Community
New Beginnings at Modera Lady Bird Mill Creek Residential has exciting news as construction kicks off for Modera Lady Bird, a vibrant mixed-use community designed to elevate the living experience with 234 rental homes. This development is poised to make a significant impact in the Northwest quadrant of Washington, D.C. Setting a New Standard for Community Living Breaking...
Continue Reading